Reporte zur Charge 0032L20A

Symptomtext

RED; SWOLLEN; warm; itchy; Uncomfortable; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (RED), VACCINATION SITE SWELLING (SWOLLEN), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE DISCOMFORT (Uncomfortable) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0032L20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (RED), VACCINATION SITE SWELLING (SWOLLEN), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE DISCOMFORT (Uncomfortable). At the time of the report, VACCINATION SITE ERYTHEMA (RED), VACCINATION SITE SWELLING (SWOLLEN), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE DISCOMFORT (Uncomfortable) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment details was reported.